YRHAM
NAGE
Yong Rong (HK) Asset Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,933,041
| Closed | -$2.38M | – | 15 |
|
|
2022
Q3 | $2.38M | Sell |
1,933,041
-775,995
| -29% | -$955K | 7.62% | 5 |
|
|
2022
Q2 | $4.53M | Sell |
2,709,036
-1,365,903
| -34% | -$2.28M | 3.53% | 9 |
|
|
2022
Q1 | $10M | Sell |
4,074,939
-56,378
| -1% | -$139K | 14.16% | 5 |
|
|
2021
Q4 | $15.5M | Hold |
4,131,317
| – | – | 12.21% | 2 |
|
|
2021
Q3 | $25.9M | Hold |
4,131,317
| – | – | 16.98% | 2 |
|
|
2021
Q2 | $40.7M | Hold |
4,131,317
| – | – | 10.13% | 3 |
|
|
2021
Q1 | $38.6M | Buy |
+4,131,317
| New | +$38.6M | 10.58% | 3 |
|